Highlights from our 2019 Capital Markets Day

MaxCyte Capital Markets Day 2019
Welcome and Introduction – Doug Doerfler, President & CEO


Enabling Technologies: Role of Flow Electroporation® – John McCafferty, PhD, Founder and CEO, IONTAS


Immuno-Oncology Landscape and CARMA™ Differentiation – Christina M. Annunziata, MD, PhD, Principal Investigator and Clinical Director, NCI


CARMA – the Clinical Pathway and Future Opportunities – Claudio Dansky Ullmann, MD, Chief Medical Officer


Financial Overview – Ron Holtz, CFO


IR Contact

For inquiries from investors regarding MaxCyte, please contact: IR@maxcyte.com

You may also contact: Chris Welsh / Mary-Jane Elliott / Ashley Tapp at Consilium Strategic Communications maxcyte@consilium-comms.com

Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter

Sign Up